What is the drug of choice for uncomplicated community‑acquired cellulitis in the Philippines?

Drug of Choice for Cellulitis in the Philippine Setting

For uncomplicated, nonpurulent cellulitis in the Philippines, a beta-lactam antibiotic targeting streptococci—specifically oral penicillin, amoxicillin, or cephalexin (first-generation cephalosporin)—is the drug of choice for 5-6 days. 1

Clinical Approach: Distinguishing Cellulitis Type

The initial step is determining whether the cellulitis is purulent (with drainage/exudate but no drainable abscess) or nonpurulent (no drainage, exudate, or abscess), as this fundamentally changes antibiotic selection 1.

For Nonpurulent Cellulitis (Most Common)

• Primary pathogens: β-hemolytic streptococci (Group A Streptococcus) and methicillin-sensitive Staphylococcus aureus 2, 3
• First-line treatment: Beta-lactam antibiotics effective against streptococci 1
  • Oral penicillin 1
  • Amoxicillin 1
  • Cephalexin or cefazolin (first-generation cephalosporins) 1
• Duration: 5-6 days for uncomplicated cases 1
• CA-MRSA coverage is NOT routinely needed unless the patient fails to respond to beta-lactam therapy or presents with systemic toxicity 1

For Purulent Cellulitis

• Empirical CA-MRSA coverage is required pending culture results 1
• Oral antibiotic options:
  • Clindamycin (covers both streptococci and CA-MRSA) 1
  • TMP-SMX or tetracycline (doxycycline/minocycline) PLUS a beta-lactam like amoxicillin for streptococcal coverage 1
  • Linezolid (covers both pathogens) 1

Philippine-Specific Considerations

Critical caveat: The Philippines has documented patterns of antibiotic purchase without prescription, with patients frequently buying inadequate quantities (median of 3 units, often ≤10 capsules/tablets) 4. This practice promotes treatment failure and antimicrobial resistance 4.

Practical Recommendations for the Philippine Setting:

• Prescribe complete courses with clear written instructions, emphasizing the importance of finishing all medication 4
• Consider cost and availability: Penicillin and amoxicillin are typically more affordable and widely available than newer agents 1
• Avoid empirical MRSA coverage in nonpurulent cellulitis to prevent unnecessary broad-spectrum antibiotic use, which is particularly important given over-the-counter antibiotic access patterns 1, 4
• Patient education is essential: Explain that incomplete treatment leads to recurrence and resistance 4

When to Modify Initial Therapy

Add CA-MRSA coverage if:

• No clinical improvement after 48-72 hours on beta-lactam therapy 1
• Signs of systemic toxicity present 1
• Penetrating trauma, injection drug use, or known MRSA colonization 1

Duration of Therapy

• Standard duration: 5-6 days for uncomplicated nonpurulent cellulitis 1
• Extend to 7-10 days if clinical response is incomplete at 5 days 1
• Recent evidence supports shorter courses (5-6 days) as equally effective as traditional 10-14 day regimens 1

Important Pitfalls to Avoid

• Do not routinely cover MRSA in nonpurulent cellulitis—this is the most common prescribing error 1, 2
• Avoid rifampin as monotherapy or adjunctive therapy for cellulitis 1
• Do not use tetracyclines in children <8 years of age 1
• Cultures are rarely positive (<20% yield in nonpurulent cellulitis), so empirical therapy based on clinical presentation is appropriate 1